COMMUNIQUÉS West-GlobeNewswire

-
Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
29/07/2025 -
Teladoc Health Reports Second Quarter 2025 Results
29/07/2025 -
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
29/07/2025 -
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
29/07/2025 -
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
29/07/2025 -
LifeMD to Report Second Quarter 2025 Financial Results on August 5
29/07/2025 -
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
29/07/2025 -
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
29/07/2025 -
Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
29/07/2025 -
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
29/07/2025 -
Larimar Therapeutics Announces Proposed Underwritten Public Offering
29/07/2025 -
Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints
29/07/2025 -
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
29/07/2025 -
Inventiva publie ses informations financières préliminaires du premier semestre 2025¹
29/07/2025 -
2025 Half-Year results
29/07/2025 -
Résultats semestriels 2025
29/07/2025 -
Belly Fat Burner: Why Men and Women are Using Strong Over the Counter Diet Supplements like PhenQ to Lose Stubborn Abdominal Fat
29/07/2025 -
LifeLabs Deepens Support to Communities Impacted by Saskatchewan Wildfires with an Additional $5,000 Donation
29/07/2025 -
Hapbee Launches Integrated Affiliate and Ambassador Program to Accelerate Growth and Community Expansion
29/07/2025
Pages